The marijuana revolution is taking over the country.
Eight states – Alaska, California, Colorado, Maine, Maryland, Massachusetts, Oregon, and Washington – and the District of Columbia have fully legalized possession of small amounts of marijuana for adults’ recreational use. An additional 13 states have decriminalized it. And 29 states, along with Puerto Rico and Guam, now allow the use of medical marijuana.
The widespread legalization has caused the industry to absolutely explode with newfound wealth.
Last year, legal pot sales rose a stunning 34%, to $6.7 billion across North America, according to Arcview Market Research. What’s more, that figure should surpass $8 billion by 2018 and reach $22.6 billion by 2021.
We’ve seen pot stocks absolutely soar from all of this growth.
Over the past year, Money Morning Director of Technology & Venture Capital Research – and our pot stock expert – Michael A. Robinson’s legal marijuana recommendations included 10 double-digit winners and eight triple-digit winners… 291% gains… 193.3%… 185.5%; one recommendation even saw peak gains of 1,588%.
best shares: Maui Land & Pineapple Company, Inc.(MLP)
- [By ]
A flurry of mergers in the master-limited partnership (MLP) segment for pipeline companies rocked the energy sector on Thursday, drawing a sanguine response from Wall Street analysts that generally supported the new, more simplified structures.
best shares: AxoGen, Inc.(AXGN)
- [By Shane Hupp]
AxoGen, Inc (NASDAQ:AXGN) – Analysts at William Blair raised their Q2 2018 earnings estimates for AxoGen in a research report issued on Monday, May 14th. William Blair analyst K. Krum now expects that the medical equipment provider will post earnings per share of ($0.04) for the quarter, up from their prior forecast of ($0.05). William Blair currently has a “Outperform” rating on the stock. William Blair also issued estimates for AxoGen’s Q4 2018 earnings at ($0.03) EPS and FY2018 earnings at ($0.25) EPS.
best shares: CME Group Inc.(CME)
- [By Stephan Byrd]
Massachusetts Financial Services Co. MA cut its position in shares of CME Group (NASDAQ:CME) by 1.8% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 445,259 shares of the financial services provider’s stock after selling 7,975 shares during the quarter. Massachusetts Financial Services Co. MA owned 0.13% of CME Group worth $72,016,000 as of its most recent filing with the SEC.
- [By Dan Caplinger]
Last December, two major futures exchanges started offering futures contracts on bitcoin. CBOE Global Markets (NASDAQ:CBOE) was the first to market with its futures offering, and CME Group (NASDAQ:CME) didn’t waste any time coming out with its own version of a bitcoin contract.
- [By ]
CME Group (Nasdaq: CME) is the world’s largest and most diverse futures exchange group, operating in four segments — the Chicago Mercantile Exchange, the Chicago Board of Trade, the New York Mercantile Exchange and the Commodity Exchange.
best shares: Concert Pharmaceuticals, Inc.(CNCE)
- [By Stephan Byrd]
Teachers Advisors LLC boosted its position in Concert Pharmaceuticals (NASDAQ:CNCE) by 293.9% during the fourth quarter, Holdings Channel reports. The fund owned 135,399 shares of the biotechnology company’s stock after purchasing an additional 101,026 shares during the quarter. Teachers Advisors LLC’s holdings in Concert Pharmaceuticals were worth $3,503,000 at the end of the most recent quarter.